An image taken from a YouTube video shows results of a rapid blood test developed by Johns Hopkins researchers that can confirm in minutes if a person has been vaccinated for SARS-CoV-2, the virus that causes COVID-19.

Source: Robert Kruse

News • Covid-19

Rapid blood test detects vaccination

A team of Johns Hopkins researchers has developed a rapid blood test that could confirm a person has been vaccinated while they wait to board a plane or enter a sporting event.

Their Covid-19 antibody test is similar to one used at home to determine blood type, where the user pricks a finger and places a drop of blood on a card. A fusion protein developed by the research team is housed on the card and detects Covid-19 antibodies, tiny proteins in the blood the immune system produces to "remember" viral encounters and provide immunity to future infections. Results come back in less than five minutes, faster than current lateral flow tests to detect antibodies at point of care, while also potentially providing a clearer result.

Robert Kruse, M.D., Ph.D., who created the blood test, says it could be used to confirm a person's vaccination instead of having to show a vaccine card. "If a business is using the honor system for vaccinations, now they could test people on-site," he says.

Kruse is lead author of a paper posted online earlier this month that reported results of the test on 400 blood samples, half of which were from prior Covid-19 patients. The test correctly identified antibodies in previously infected patients 87.5% of the time, a slightly higher rate than ELISA tests performed in hospitals that require hours to perform. The paper is being peer-reviewed.

Recommended article

Photo

News • Coronavirus disease biomarkers

New Covid-19 testing method gives results within one second

The Covid-19 pandemic made it clear technological innovations were urgently needed to detect, treat, and prevent the SARS-CoV-2 virus. A year and a half into this epidemic, waves of successive outbreaks and the dire need for new medical solutions — especially testing — continue to exist. In the Journal of Vacuum Science & Technology B, researchers from the University of Florida and…

The test uses hemagglutination, in which the degree of clumping together of red blood cells reveals the concentration of antibodies. Kruse, a pathology resident at the Johns Hopkins University School of Medicine, said the hemagglutination results could let people know if they still have protection months after they received the vaccine or if they need a booster shot. The degree of hemagglutination also correlated with levels of neutralizing antibodies in patients, which protect against viral infection.

Immunocompromised patients, who studies have shown don't always respond to the COVID-19 vaccine, could test their antibody level and see if the vaccine is working for them, says Yuting Huang, M.D., Ph.D., Kruse's co-author and a research fellow at Johns Hopkins as well as chief resident of internal medicine at the University of Maryland Medical Center Midtown Campus.                                         

Kruse and Huang developed the test in the lab of Zack Z. Wang, Ph.D., an associate professor at Johns Hopkins in the Division of Hematology. Kruse says the research is an example of the "Hopkins network coming through": Colleagues in pathology connected Kruse and Huang with researchers from the Johns Hopkins Bloomberg School of Public Health who already had patient samples and test results they were using for their own COVID-19 studies, allowing for collaboration and data-sharing.

"If those collaborating labs didn't have those samples, we wouldn't really have known how well it worked," says Kruse. Johns Hopkins Technology Ventures is seeking patent protection for the technology, which is available for licensing. The test's creators are seeking an industry collaborator to manufacture the cards and have applied for funding through TEDCO's Maryland Innovation Initiative to assist in commercializing its research.           

Source: John Hopkins University                                                                                                            

08.06.2021

Read all latest stories

Related articles

Photo

News • Protein malformation

Covid-19: immune reaction may cause amyloid generation

In patients with serious and long-term Covid-19, disturbed blood coagulation is often observed. Now, Swedish researchers found a connection between harmful amyloid production and Covid-19 symptoms.

Photo

News • Causal link found

Does your blood group affect risk for severe Covid-19?

A new study has analyzed over 3000 proteins to identify which are causally linked to the development of severe Covid-19. This provides insight into potential new targets for treatment and prevention.

Photo

News • Sensitivity and response detection

How long do tests detect SARS-CoV-2 antibodies? New insights

How long can Covid-19 antigen tests reliably tell the antibody status? Researchers at the Paul-Ehrlich-Institut identified several factors that affect the detection duration.

Related products

Beckman Coulter – SARS-CoV-2 Assays

Immunoassays

Beckman Coulter – SARS-CoV-2 Assays

Beckman Coulter Diagnostics
Lifotronic – SARS-CoV-2 Nucleic Acid Detection Kit

Detection

Lifotronic – SARS-CoV-2 Nucleic Acid Detection Kit

Lifotronic Technology Co., Ltd
Nova Biomedical – StatStrip Glucose/Ketone*

Blood Glucose

Nova Biomedical – StatStrip Glucose/Ketone*

Nova Biomedical Corporation
Shimadzu – CLAM-2030

Mass Spectrometry

Shimadzu – CLAM-2030

Shimadzu Europa GmbH
Subscribe to Newsletter